Vaccine News and Research

Latest Vaccine News and Research

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

The Food and Drug Administration (FDA) has identified about 5 million doses of influenza vaccine from foreign manufacturers; HHS has been able to recoup an additional 300,000 doses of the injectable vaccine originally bought for federal employees and the military; and a major pneumonia vaccine manufacturer plans to triple its production.

29 Oct 2004

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

A team of scientists at Tufts University School of Veterinary Medicine has helped decode the genome sequence of Cryptosporidium hominis, an insidious parasite identified as one of the most common causes of waterborne diseases in humans and classified by the Centers for Disease Control and Prevention as a potential bioterrorist agent.

29 Oct 2004

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

A potential new therapeutic approach to Alzheimer's disease protects brain cells in culture by drastically reducing the neurotoxic amyloid protein aggregates that are critical to the development of the disease.

29 Oct 2004

Study suggests safer immunization approach to Alzheimer's

Researchers at the University of Illinois at Chicago have had preliminary success with a method of immunization intended to dissolve the plaques in brain tissue that are associated with Alzheimer's disease.

28 Oct 2004

An immune system in a bottle would allow faster and easier production of a flu vaccine

University of Michigan associate professor Nicholas Kotov believes that one day, the cells in those honeycombs can be used to grow spare parts for our bodies, or even an entire artificial immune system in a bottle.

26 Oct 2004

Easy-to-make vaccine tackles a range of illnesses

Australian researchers have created a totally synthetic vaccine that is effective against viruses, harmful bacteria and tumours and could lead to a powerful new arsenal of vaccines for humans and animals.

26 Oct 2004

Arizona will receive 22,500 additional doses of flu vaccine

Arizona Governor Janet Napolitano announced today that Arizona will receive 22,500 additional doses of flu vaccine as early as Wednesday, and will distribute the vaccine to local health departments in the next week.

25 Oct 2004

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Highly active antiretroviral therapy (HAART) for the treatment of individuals infected by HIV-1 is limited by high costs, drug resistance, and drug-related toxicities. This has led researchers to investigate new treatment options, including ways to boost immune responses to better control HIV.

25 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

Study could lead to new, more effective treatments for urinary tract infections

Anyone who thinks scientists lead a glamorous, exciting life should talk to Jennifer Snyder, a graduate student at the University of Maryland’s School of Medicine.

25 Oct 2004

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK. The vaccine, devised by a team led by Dr Helen McShane in Oxford’s Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), is designed to be used in tandem with the tried and tested BCG inoculation – first introduced in 1921 – and not to replace it.

25 Oct 2004

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Alzheimer's disease is characterized by progressive loss of cognitive function due to amyloid-beta (Aß) deposits in the central nervous system. If these deposits could be stopped or slowed, Alzheimer's disease might become more manageable.

25 Oct 2004

Infectious diseases physicians call for financial incentives for industry

In the midst of the current national shortage of influenza vaccine, the Infectious Diseases Society of America (IDSA) has renewed its call for Congress and the Administration to implement innovative public policy geared toward removing financial disincentives that have caused pharmaceutical companies to leave the vaccine market.

25 Oct 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

Who should and who should not get a flu shot?

This year's supply of flu vaccine is limited. It is important that people at highest risk of serious illness or death from the flu get a flu shot. Complete this CDC form to see if you or your child should or should not get a flu shot.

25 Oct 2004

BMA report hopes to raise awareness about the threat of biological weapons

A new report released today (25 October 2004) by the BMA paints a bleak picture of the global community's ability to cope with advances in biological and genetic weapons technology.

25 Oct 2004

MedImmune bumps up production of FluMist vaccine

MedImmune has announced that it is increasing its planned delivery of FluMist (Influenza Virus Vaccine Live, Intranasal) up to a total of three million doses. Originally the company had completed production of 1.1 million doses.

22 Oct 2004

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

MedImmune announced that it has initiated a pivotal head-to-head Phase 3 clinical trial designed to compare its next-generation, refrigerator- stable intranasal influenza vaccine (CAIV-T: cold adapted intranasal influenza vaccine, trivalent) with the injectable flu shot (TIV: trivalent influenza vaccine).

22 Oct 2004

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

The discovery that the Lag-3 gene acts as a brake to prevent immune system responses from running out of control solves a mystery that has puzzled researchers since the gene was discovered 14 years ago.

22 Oct 2004

Research findings will likely aid efforts to develop a vaccine for Leishmania major

Researchers at Washington University School of Medicine in St. Louis and the University of Pennsylvania have found an immune system cell can "remember" a parasite's attack and help the body mount a more effective defense against subsequent invasions by the same parasite.

21 Oct 2004

Vaccine News and Research

Latest Vaccine News and Research

U.S. Department of Health & Human Services has announced progress toward expanding the nation's supply of vaccines for flu season

Scientists decode the genome sequence of Cryptosporidium hominis, one of the most common causes of waterborne diseases in humans

Trojan horse technique offers potential new therapeutic approach to Alzheimer's disease

Study suggests safer immunization approach to Alzheimer's

An immune system in a bottle would allow faster and easier production of a flu vaccine

Easy-to-make vaccine tackles a range of illnesses

Arizona will receive 22,500 additional doses of flu vaccine

Researchers investigate new treatment options, including ways to boost immune responses to better control HIV

Scientists are testing the effectiveness of a new type of flu vaccine

Study could lead to new, more effective treatments for urinary tract infections

The first new TB vaccine for more than 80 years has successfully come through safety trials in the UK

New oral vaccine treatment is effective in reducing Alzheimer's disease pathology

Infectious diseases physicians call for financial incentives for industry

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

Who should and who should not get a flu shot?

BMA report hopes to raise awareness about the threat of biological weapons

MedImmune bumps up production of FluMist vaccine

MedImmune initiates clinical trial comparing intranasal influenza vaccine with injectable flu vaccine

Lag-3 gene dampens immune responses by controlling regulatory T-cell function

Research findings will likely aid efforts to develop a vaccine for Leishmania major

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Vaccine News and Research

Latest Vaccine News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in